ResearcherUniversity of Southern CaliforniaNo recent work listed
Divya Pathania
Matched on ORCID iD 0000-0001-6454-0768; OpenAlex author ID A5074605598. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2014: 1 paper · 2015: 1 paper · 2016: 1 paper
Papers 3
- Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.jmedchem.5b01571↗
- Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells. Co-author DOI 10.1111/bph.12855↗
- Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer. Co-author DOI 10.1016/j.bbagen.2013.08.005↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mario Sechi · 3 shared papers, 2014–2016 · strength 0.18
- Paper Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer c… DOI 10.1111/bph.12855↗
- Paper Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. DOI 10.1021/acs.jmedchem.5b01571↗
- Paper Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer. DOI 10.1016/j.bbagen.2013.08.005↗
- Nouri Neamati · 3 shared papers, 2014–2016 · strength 0.18
- Paper Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer c… DOI 10.1111/bph.12855↗
- Paper Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. DOI 10.1021/acs.jmedchem.5b01571↗
- Paper Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer. DOI 10.1016/j.bbagen.2013.08.005↗
- Vanna Sanna · 2 shared papers, 2014–2016 · strength 0.11
- Yuting Kuang · 1 shared paper, 2015 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.